Grace Therapeutics, Inc. (GRCE) vs Metagenomi Therapeutics, Inc. (MGX)
Grace Therapeutics, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Grace Therapeutics, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($45.4M and $43.4M). Grace Therapeutics, Inc. grew revenue faster over the last twelve months: 1,286.8% against −59.8%. Grace Therapeutics, Inc. has the higher net margin (0.00% vs −689.2%) and the lower return on invested capital (−43.4% vs 0.00%). Across the 16 metrics below, Grace Therapeutics, Inc. leads on 11 and Metagenomi Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | GRCE | MGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (741.58%) | 0.00% |
| Net margin | 0.00% | (689.20%) | 0.00% |
| Free cash flow margin | 0.00% | (632.67%) | 0.00% |
| Return on equity | (36.19%) | (60.61%) | (57.72%) |
| Return on assets | (33.74%) | (41.91%) | (49.22%) |
| Return on invested capital | (43.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack